Micromobility.com Inc. MCOM
At closeNov 2, 2026, 4:00 PM EST
- YTD
- -99.07%
- 1 year
- -98.13%
Discussion (75)
Sign in to join the discussion
Someone should put Palella on suicide watch.
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $13 Price Target
3 weeks ago, November 15, 2023 at 10:24 AM EST
Via Analyst Upgrades
ACXP
Share
HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals with a Buy and maintains $13 price target.
? look also ACXP 100% approved
Acurx Announces Positive Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical Cure
All 15 ibezapolstat-treated patients in Phase 2b who achieved Clinical Cure (CC) at end of treatment (EOT) remained free of C. difficile Infection (CDI) recurrence through one month after EOT, for a Sustained Clinical Cure (SCC) rate of 100%
2 of 14 patients treated with standard of care, oral vancomycin, experienced recurrent infection within one month after EOT for a SCC of 86%
10
News
$MICROMOBILITY.COM (MCOM.US)$ micromobility.com Inc. Slashes Debt by $9.25 Million in Strategic Financial Triumph
1 MINUTE AGO, 7:25 AM EST
VIA BUSINESSWIRE
Just now Announced
micromobility.com Inc. Slashes Debt by $9.25 Million in Strategic Financial Triumph
7 minutes ago, 7:25 AM EST
Via BusinessWire
MCOM
Share
micromobility.com Inc. (NASDAQ:MCOM) announces a landmark achievement in its financial strategy, significantly reducing its debt and setting a course for profitability. The Company has successfully implemented a Settlement and Release Agreement, leading to a major reduction in its debt burden.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231211437447/en/
